Hepatitis C virus quasispecies and response to interferon therapy in patients with chronic hepatitis C: A prospective study

Journal of Viral Hepatitis

Volumn 7, Issue 1, 2000, Pages 36-42

  Hino, Keisuke ^a   Yamaguchi, Y ^a   Fujiwara, D ^a   Katoh, Y ^a   Korenaga, M ^a   Okazaki, M ^a   Okuda, M ^a   Okita, K ^a   Kawamura, S ^b   Ariyama, S ^b   Tanabe, M ^b   Inamoto, Y ^b   Murakami, A ^c   Nishimura, S ^c   Harada, T ^d   Fukumoto, Y ^d   Kajii, N ^d   Hirado, H ^d   Mizumachi, S ^e   Yamasaki, T ^e   Andoh, K ^f   Esaki, T ^f   Harada, Y ^g   Sanuki, K ^g   Terai, K ^h   Inoue, M ⁱ   Shigeta, K ⁱ   Kubo, Y ^j   Konishi, T ^k   more..

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI ROSAI HOSPITAL   (Japan)

^c Onoda City Hospital   (Japan)

^d Kanmon Medical Center   (Japan)

^e Shimonoseki City Hospital   (Japan)

^f Yamaguchi Saiseikai General Hospital   (Japan)

^g Ube Kohsan Chuoh Hospital   (Japan)

^h Sanyoh Chuoh Hospital   (Japan)

ⁱ Tokuyama Central Hospital   (Japan)

^j Hikari Shiritsu Hospital   (Japan)

^k Shuhtoh General Hospital   (Japan)

more..

Author keywords

Hypervariable region; Nucleotide diversity; Predictive factor; Single strand conformation polymorphism

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; VIRUS RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE STRAND CONFORMATION POLYMORPHISM; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; INTERFERON-ALPHA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; TREATMENT OUTCOME;

EID: 0034056076     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2000.00196.x     Document Type: Article

References (34)

1. 1 Yoshioka K, Kakumu S, Wakita T et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293-299.
2. 2 Hino K, Sainokami S, Shimoda K et al. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol 1994; 42: 299-305.
3. 3 Kanai K, Kako M, Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon. Lancet 1992; 339: 1543.
4. 4 Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995; 122: 161-168.
5. 5 Martell M, Esteban JI, Quer J et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1993; 66: 3225-3229.
6. 6 Oshima M, Tsuchiya M, Yagasaki M et al. cDNA clones of Japanese hepatitis C virus genomes derived from a single patient show sequence heterogeneity. J Gen Virol 1991; 72: 2805-2809.
7. 7 Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 1991; 175: 220-228.
8. 8 Weiner AJ, Brauer MJ, Rosenblatt J et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 1991; 180: 842-848.
9. 9 Kato N, Ootsuyama Y, Tanaka T et al. Marked sequence diversity in the putative envelope proteins of chronic hepatitis C virus. Virus Res 1992; 22: 107-123.
10. 10 Okada S, Akahane Y, Suzuki H, Okamoto H, Mishiro S. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with the responsiveness to interferon therapy in viremic patients. Hepatology 1992; 16: 619-624.
11. 11 Kanazawa Y, Hayashi N, Mita E. et al. Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients. Hepatology 1994; 20: 1121-1130.
12. 12 Moribe T, Hayashi N, Kanazawa Y et al. Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy. Gastroenterology 1995; 108: 789-795.
13. 13 Koizumi K, Enomoto N, Kurosaki M et al. Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology 1995; 22: 30-35.
14. 14 Yun ZB, Odeberg J, Lundeberg J, Weiland O, Uhlen M, Sonnerborg A. Restriction of hepatitis C virus heterogeneity during prolonged interferon-α therapy in relation to changes in virus load. J Infect Dis 1996; 173: 992-996.
15. 15 Yeh BI, Han KH, Oh SH et al. Nucleotide sequence variation in the hypervaríable regíon of the hepatítís C virus in the sera of chronic hepatitis C patients undergoing controlled interferon-α therapy. J Med Virol 1996; 49: 95-102.
16. 16 Shindo M, Hamada K, Koya S, Arai K, Sokawa Y, Okuno T. The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy. Hepatology 1996; 24: 1018-1023.
17. 17 Toyoda H, Kumada T, Nakano S et al. Quasispecies nature of hepatitis C virus and response to alpha interferon: significance as a predictor of direct response to interferon. J Hepatol 1997; 26: 6-13.
18. 18 Polyak SJ, Faulkner G, Carithers RL, Corey L Jr, Gretch DR. Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis: correlation with response to interferon therapy. J Infect Dis 1997; 175: 1101-1107.
19. 19 Le Guen B, Squadrito G, Nalpas B, Berthelot P, Pol S, Brechot C. Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C. Hepatology 1997; 25: 1250-1254.
20. 20 Takagi H, Takehara K, Shimoda R et al. Prediction of effect of interferon on chronic hepatitis C. Dig Dis Sci 1997; 42: 2270-2276.
21. 21 Pawlotsky JM, Pellerin M, Bouvier M et al. Genetic complexity of the hypervariable region 1 (HVR 1) of hepatitis C virus (HCV): influence on the characteristics of the infection and response to interferon alpha therapy in patients with chronic hepatitis C. J Med Virol 1998; 54: 256-264.
22. 22 Nakazawa T, Kato N, Ohkoshi S, Shibuya A, Shimotohno K. Characterization of the 5′ noncoding and structural region of the hepatitis C virus genome from patients with non-A, non-B hepatitis responding differently to interferon treatment. J Hepatol 1994; 20: 623-629.
23. 23 Cao K, Mizokami M, Orito E et al. Nucleotide and amino acid diversities of E2/NS1 hypervariable region 1 and response to interferon therapy in patients with chronic hepatitis C virus infection. Hepatol Res 1998; 11: 166-177.
24. 24 Xavier F, Labrador L, Ampurdanes S et al. Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection. Hepatology 1999; 29: 897-903.
25. 25 Young KK, Resnick RM, MyersTW. Detection of hepatitis C virus RNA by combined reverse transcription-polymerase chain reaction assay. J Clin Microbiol 1993; 31: 882-886.
26. 26 Okamoto H, Sugiyama Y, Okada S et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673-679.
27. 27 Simmonds P, Alberts A, Alter HJ et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 1321-1324.
28. 28 Sugano M, Hayashi Y, Yoon S et al. Quantitation of hepatitis C viral RNA in liver and serum samples using competitive polymerase chain reaction. J Clin Pathol 1995; 48: 820-825.
29. 29 Toyoda H, Fukuda Y, Koyama Y et al. Nucleotide sequence diversity of hypervariable region 1 of hepatitis C virus in Japanese hemophiliacs with chronic hepatitis C and patients with chronic posttransfusion hepatitis C. Blood 1996; 88: 1488-1493.
30. 30 Hultman T, Stahl S, Hornes E, Uhlen M. Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. Nucl Acids Res 1989; 17: 4937-4946.
31. 31 Okamoto H, Okada S, Sugiyama Y et al. Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions. J Gen Virol 1991; 72: 2697-2704.
32. 32 Hino K, Okuda M, Korenaga M et al. Clinical evaluation of chronic liver diseases induced by different hepatitis C virus genotype in Japan, focused on the different between genotypes III/2a and IV/2b. Hepatol Res 1999; 14: 204-211.
33. 33 Kohara M, Tanaka T, Tsukiyama-Kohara K et al. Hepatitis C virus genotypes 1 and 2 respond to interferon-α with different virologic kinetics. J Infect Dis 1995; 172: 934-938.
34. 34 Toyoda H, Nakano S, Kumada T et al. Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-α therapy in chronic hepatitis C patients. J Med Virol 1996; 48: 354-359.